This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Silvia Leis De Cerone: Innovator in Monoclonal Antibodies
Introduction
Silvia Leis De Cerone is a prominent inventor based in Buenos Aires, Argentina. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her work focuses on innovative solutions for cancer diagnosis and treatment.
Latest Patents
Silvia holds a patent for "Monoclonal antibodies reactive with tumor proliferating cells." This invention is particularly relevant to breast carcinoma, as it involves the production of immunoglobulin-secreting hybridoma cultures. These cultures are created using undifferentiated breast cancer cells as antigens for immunization. The selected hybridomas produce antibodies that are highly reactive with tumor proliferating cells. This advancement has important applications in aiding the diagnosis and treatment of cancer.
Career Highlights
Throughout her career, Silvia has demonstrated a commitment to advancing medical science. Her innovative approach to developing monoclonal antibodies has positioned her as a key figure in cancer research. With a patent portfolio that includes her groundbreaking work, she continues to influence the field significantly.
Collaborations
Silvia has collaborated with notable professionals in her field, including Jose Mordoh and Osvaldo Luis Podhajcer. These partnerships have enhanced her research and contributed to the success of her inventions.
Conclusion
Silvia Leis De Cerone is a trailblazer in the field of biotechnology, particularly in the development of monoclonal antibodies for cancer treatment. Her innovative work and collaborations have made a lasting impact on medical research and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile